|
|
||||||||
|
FIGURE 2. (A) CCS angina pectoris classification at baseline and after 3 mo of follow-up in 3 groups (control, standard therapy; DMR, laser treatment; VEGF, VGEF gene therapy). Changes were significantly different between the 3 groups (P < 0.001). (B) Change in CCS class in 3 individual groups. Change in VEGF gene therapy group was significantly different from that of other 2 groups (P < 0.05).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |